Irinotecan Hydrochloride 100286-90-6
| Systematic (IUPAC) name: |
(S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo1H-pyrano[3,46,7]-indolizino[1,2-b]quinolin-9-yl-[1,4bipiperidine]-1-carboxylate |
| Irinotecan Hydrochloride CAS number: |
100286-90-6 |
| ATC code: |
L01XX19 |
| PubChem: |
3750 |
| DrugBank: |
APRD00579 |
| Formula: |
C33H38N4O6 |
| Molecular mass: |
586.678 g/mol |
| Irinotecan Hydrochloride Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
